Quantcast
Last updated on April 17, 2014 at 7:47 EDT

Latest Mild cognitive impairment Stories

2012-07-18 06:28:00

- Phase 2b study of a new symptomatic drug - - One-year extension trial of a medical food - - 9-month trial of a dietary supplement - - 18-month study of a home-based care coordination intervention - VANCOUVER, British Columbia, July 18, 2012 /PRNewswire-USNewswire/ -- Results from four clinical trials reported at the Alzheimer's Association International Conference® 2012 (AAIC® 2012) demonstrate the wide variety of approaches being pursued to improve memory, thinking, quality...

2012-07-18 06:26:41

VANCOUVER, British Columbia, July 18, 2012 /PRNewswire-USNewswire/ -- New studies reported at the Alzheimer's Association International Conference 2012 (AAIC® 2012), July 14-19, in Vancouver cover the spectrum of Alzheimer's disease and dementia research, including causes, risk factors, detection and diagnosis, treatment, and prevention. The Alzheimer's Association International Conference is the premier annual forum for presentation and discussion of the latest Alzheimer's and...

2012-07-18 01:06:44

Early diagnosis without treatment options creates individual, societal conundrum Diagnostic tests are increasingly capable of identifying plaques and tangles present in Alzheimer's disease, yet the disease remains untreatable. Questions remain about how these tests can be used in research studies examining potential interventions to treat and prevent Alzheimer's disease. Experts from the Perelman School of Medicine at the University of Pennsylvania will today participate in a panel at the...

2012-07-17 06:25:37

VANCOUVER, British Columbia, July 17, 2012 /PRNewswire-USNewswire/ -- With FDA approval of a brain amyloid imaging compound in early 2012 and the expected start in 2012 and 2013 of three clinical trials in people with pre-symptomatic Alzheimer's disease, issues around disclosure of dementia risk status are becoming more urgent. Several research efforts reported today at the Alzheimer's Association International Conference® 2012 (AAIC® 2012) describe the creation and evaluation of new...

2012-07-16 10:25:43

Findings from the Einstein Aging Study Presented at the Alzheimer's Association International Conference This Week BRONX, N.Y., July 16, 2012 /PRNewswire-USNewswire/ -- Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that people with a form of mild cognitive impairment (MCI), a risk factor for developing Alzheimer's disease, have twice the risk of dying compared with cognitively normal people. Those with dementia have...

2012-07-16 10:25:25

Evidence Supports Benefits of Physician Attention and Social Engagement VANCOUVER, British Columbia, July 16, 2012 /PRNewswire-USNewswire/ -- Two studies presented today at the Alzheimer's Association International Conference® 2012 (AAIC® 2012) in Vancouver provide evidence of connections between mild cognitive impairment (MCI) and negative health outcomes - increased isolation and death. These studies suggest that MCI, which is too often thought of as "only a little memory...

2012-07-16 06:27:09

VANCOUVER, British Columbia, July 16, 2012 /PRNewswire-USNewswire/ -- Four studies reported today at the Alzheimer's Association International Conference® 2012 (AAIC® 2012) in Vancouver suggest a relationship between sleep quality and quantity and risk of cognitive decline, and that interventions to normalize sleep duration and correct sleep disorders may not only improve quality of life, but have potential to reduce or prevent cognitive decline. "We know that sleep patterns change...

2012-07-16 02:23:52

TSX Exchange Symbol: RVX Dr. Bengt Winblad Appointed Chairman of the Clinical & Scientific Advisory Board Alzheimer's Association International Conference, Vancouver BC, July 16, 2012 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) today announced the formation of a clinical & scientific advisory board to support the clinical development of its lead drug candidate RVX-208 and follow-on bromodomain inhibitors in neurodegenerative diseases such as Alzheimer's disease, mild...

Walking Ability Precursor To Alzheimer’s Disease
2012-07-16 08:39:11

Lawrence LeBlond for redOrbit.com - Your Universe Online A person´s walking patterns or ability to do so could be an early warning sign of cognitive decline and warrants advanced testing, according to researchers at a health conference on Sunday. The findings are the result of three studies linking changes in walking ability to a weakening mental state, an early sign of dementia or Alzheimer´s disease. The findings were reported at the Alzheimer´s Association...

2012-07-15 06:20:20

Resistance Training Emerging as Particularly Valuable for Older Adults VANCOUVER, British Columbia, July 15, 2012 /PRNewswire-USNewswire/ -- Four studies reported today at the Alzheimer's Association International Conference® 2012 (AAIC® 2012) describe the ability of targeted exercise training to promote improved mental functioning and reduced risk for cognitive impairment and dementia in cognitively healthy older adults and those with mild cognitive impairment (MCI). The...